| Literature DB >> 30166908 |
F M Alsaleh1, J Lemay2, R R Al Dhafeeri3, S AlAjmi3, E A Abahussain1, T Bayoud1.
Abstract
INTRODUCTION: To improve patient safety and care, the identification and reporting of adverse drug reactions (ADRs) should be systematic and mandatory for all healthcare professionals (HCPs). Physicians remain the main HCPs with direct patient care whose role in ADRs reporting should not be ignored.Entities:
Keywords: Adverse drug reactions; Government; Hospitals; Pharmacovigilance; Physicians; Private
Year: 2017 PMID: 30166908 PMCID: PMC6111136 DOI: 10.1016/j.jsps.2017.09.002
Source DB: PubMed Journal: Saudi Pharm J ISSN: 1319-0164 Impact factor: 4.330
Sociodemographic characteristics of the physicians working in private and government hospitals in Kuwait (n = 852).
| All | Private | Government | p-value | ||||
|---|---|---|---|---|---|---|---|
| 852 | (100) | 302 | (35.4%) | 550 | (64.5%) | ||
| n | (%) | n | (%) | n | (%) | ||
| Male | 584 | (69.3) | 220 | (72.8) | 364 | (67.3) | |
| Female | 259 | (30.7) | 82 | (27.2) | 177 | (32.7) | |
| Kuwaiti | 209 | (25.0) | 35 | (11.6) | 174 | (32.6) | |
| Non-Kuwaiti | 626 | (75.0) | 267 | (88.4) | 359 | (67.4) | |
| 20–29 | 98 | (11.8) | 2 | (0.7) | 96 | (18.2) | |
| 30–39 | 320 | (38.6) | 75 | (24.8) | 245 | (46.5) | |
| 40–49 | 230 | (27.7) | 116 | (38.4) | 114 | (21.6) | |
| ≥50 | 181 | (21.8) | 109 | (36.1) | 72 | (13.7) | |
| 41.0 | (10.4) | 46.6 | (9.6) | 37.8 | (9.4) | ||
| Consultant/Senior specialist | 183 | (22.1) | 107 | (35.8) | 76 | (14.4) | |
| Senior Registrar/Specialist | 173 | (20.9) | 83 | (27.8) | 90 | (17.0) | |
| Registrar/General practitioner | 368 | (44.5) | 108 | (36.1) | 260 | (49.2) | |
| Assistant registrar/Resident/Trainee | 103 | (12.5) | 1 | (0.3) | 102 | (19.3) | |
| <1 | 21 | (2.5) | 0 | (0.0) | 21 | (4.0) | |
| 1–5 | 106 | (12.8) | 3 | (1.0) | 103 | (19.5) | |
| 6–10 | 144 | (17.3) | 26 | (8.6) | 118 | (22.3) | |
| 11–15 | 195 | (23.5) | 62 | (20.5) | 133 | (25.1) | |
| 16–20 | 152 | (18.3) | 82 | (27.2) | 70 | (13.2) | |
| >20 | 213 | (25.6) | 129 | (42.7) | 84 | (15.9) | |
| Kuwait | 125 | (15.1) | 15 | (5.0) | 110 | (20.9) | |
| Outside Kuwait | 703 | (84.9) | 287 | (95.0) | 416 | (79.1) | |
Numbers may not add to the total due to missing data.
p-values were generated using Pearson Chi-square test.
p-values were generated using Independent t-test.
Egyptian (n = 178), Indian (n = 32), British (n = 10), Lebanese (n = 9), Syrian (n = 7), Bulgarian (n = 5), Pakistani (n = 4), French (n = 3), Iraqi (n = 3), Canadian (n = 3), Jordanian (n = 3), other (n = 10).
Egyptian (n = 246), Indian (n = 50), Syrian (n = 20), Pakistani (n = 7), Jordanian (n = 6), American (n = 4), Palestinian (n = 3), other (n = 23).
Egypt (n = 176), India (n = 31), UK (n = 21), France (n = 6), Canada (n = 6), Ireland (n = 6), Syria (n = 5), Pakistan (n = 4), Bulgaria (n = 4), Jordon (n = 4), Lebanon (n = 3), Russia (n = 3), Iraq (n = 3), other (n = 15).
Egypt (n = 252), India (n = 46), Ireland (n = 20), Syria (n = 18), UK (n = 16), Bahrain (n = 14), USA (n = 7), Pakistan (n = 6), Russia (n = 4), Jordan (n = 4), Malta (n = 3), other (n = 26).
Knowledge of PV and ADRs among private and government physicians (n = 852).
| All | Private | Government | p-value | ||
|---|---|---|---|---|---|
| 852 | 302 (35.4%) | 550 (64.5%) | |||
| n (%) | N (%) | N (%) | |||
| Know correct definition of PV | 404 (47.4) | 147 (48.7) | 257 (46.7) | 0.586 | |
| Know correct purpose of PV | 583 (68.5) | 227 (75.2) | 356 (64.8) | 0.002 | |
| Know correct definition of ADRs | 588 (69.0) | 229 (75.8) | 359 (65.3) | 0.001 | |
| Know ADRs that should be reported | 654 (76.8) | 231 (76.5) | 423 (76.9) | 0.890 | |
| Any center or ADR reporting system in Kuwait? | 0.004 | ||||
| Yes | 43 (5.1) | 24 (7.9) | 19 (3.5) | ||
| No/Don’t know | 807 (94.9) | 278 (92.1) | 529 (96.5) | ||
PV: Pharmacovigilance; ADRs: adverse drug reactions. Numbers may not add to the total due to missing data. p-values were generated using Pearson Chi-square test.
PV is the science and activities of detecting, assessing, understanding and preventing adverse effects (WHO, 2002a).
ADRs are any noxious or undesired effect of a drug occurring at normal doses and during normal use (WHO, 2002b)
Fig. 1Physicians’ awareness on the responsible organization in Kuwait to receiving ADR reports (n = 852)*. ADRs: adverse drug reactions; MOH: Ministry of Health; KDFC: Kuwait Food and Drug Control Administration. *Multiple responses were possible.
Fig. 2Physicians’ attitude toward reporting ADRs (n = 852). ADRs: adverse drug reactions.
Fig. 3Physicians’ opinions on the qualified HCPs to reporting ADRs (n = 852)*. HCP: healthcare professionals; ADRs: adverse drug reactions. *Multiple responses were possible.
Attitudes and practices of reporting ADRs among physicians working in private and government hospitals in Kuwait (n = 852).
| All | Private | Government | p-value | ||||
|---|---|---|---|---|---|---|---|
| 852 | (100%) | 302 | (35.4%) | 550 | (64.5%) | ||
| n | (%) | n | (%) | n | (%) | ||
| Email/on Website | 522 | (61.3) | 221 | (73.2) | 301 | (54.7) | |
| Direct contact | 220 | (25.8) | 57 | (18.9) | 163 | (29.6) | |
| Telephone | 46 | (5.4) | 12 | (4.0) | 34 | (6.2) | |
| Post | 33 | (3.9) | 5 | (1.7) | 28 | (5.1) | |
| Other (e.g. mobile application) | 31 | (3.6) | 7 | (2.3) | 24 | (4.4) | |
| 0.342 | |||||||
| No/don’t know | 45 | (5.3) | 13 | (4.3) | 32 | (5.8) | |
| Yes | 806 | (94.7) | 289 | (95.7) | 517 | (94.2) | |
| No/don’t know | 113 | (13.3) | 30 | (9.9) | 83 | (15.1) | |
| Yes | 739 | (86.7) | 272 | (90.1) | 467 | (84.9) | |
| 0.213 | |||||||
| No | 216 | (25.4) | 69 | (22.8) | 147 | (26.7) | |
| Yes | 636 | (74.6) | 233 | (77.2) | 403 | (73.3) | |
| <5 | 261 | (41.0) | 109 | (46.8) | 152 | (37.7) | |
| 5–10 | 154 | (24.2) | 57 | (24.5) | 97 | (24.1) | |
| >10 | 221 | (34.7) | 67 | (28.8) | 154 | (38.2) | |
| No | 561 | (65.8) | 174 | (57.6) | 387 | (70.4) | |
| Yes | 291 | (34.2) | 128 | (42.4) | 163 | (29.6) | |
PV: Pharmacovigilance; ADRs: adverse drug reactions; HCP: healthcare professionals. Numbers may not add to the total due to missing data. p-values were generated using Pearson Chi-square test.
Factors associated with ADR reporting (0 = No, 1 = Yes) among private and government physicians in Kuwait using univariate binary logistic regression analyses.
| Factors | Private | Government | ||
|---|---|---|---|---|
| COR (95% CI) | p-value | COR (95% CI) | p-value | |
| Male | 1.00 | 1.00 | ||
| Female | 0.83 (0.49–1.39) | 0.471 | 0.69 (0.46–1.03) | 0.072 |
| Kuwaiti | 1.00 | 1.00 | ||
| Non-Kuwaiti | 1.28 (0.62–2.65) | 0.505 | 2.37 (1.53–3.66) | |
| 20–29 | 1.00 | 1.00 | ||
| 30–39 | 0.63 (0.04–10.48) | 0.748 | 2.64 (1.35–5.13) | |
| 40–49 | 0.79 (0.05–12.85) | 0.865 | 3.78 (1.85–7.75) | |
| ≥50 | 0.76 (0.05–12.44) | 0.846 | 8.27 (3.86–17.73) | |
| ≤10 | 1.00 | 1.00 | ||
| 11–20 | 1.54 (0.66–3.62) | 0.320 | 2.29 (1.49–3.53) | |
| >20 | 1.93 (0.82–4.56) | 0.133 | 4.06 (2.38–6.94) | |
| Kuwait | 1.00 | 1.00 | ||
| Outside Kuwait | 0.63 (0.22–1.78) | 0.382 | 2.06 (1.23–3.46) | |
| Consultant/Senior Specialist | 1.40 (0.81–2.42) | 0.223 | 4.59 (2.28–9.23) | |
| Senior Registrar/Specialist | 1.53 (0.86–2.73) | 0.152 | 3.26 (1.65–6.46) | |
| Registrar/General practitioner | 1.00 | 2.06 (1.13–3.75) | ||
| Assistant registrar/Resident/ Trainee | 1.00 | |||
| No | 1.00 | 1.00 | ||
| Yes | 1.29 (0.82–2.04) | 0.274 | 1.14 (0.79–1.65) | 0.473 |
| No | 1.00 | 1.00 | ||
| Yes | 1.32 (0.77–2.26) | 0.308 | 1.93 (1.29–2.91) | |
| No | 1.00 | 1.00 | ||
| Yes | 1.00 (0.58–1.70) | 0.987 | 1.30 (0.88–1.92) | 0.196 |
| No | 1.00 | 1.00 | ||
| Yes | 1.89 (1.07–3.33) | 2.10 (1.29–3.42) | ||
| No | 1.00 | 1.00 | ||
| Yes | 2.96 (1.23–7.16) | 7.14 (2.53–20.17) | ||
| No | 1.00 | 1.00 | ||
| Yes | 1.69 (0.51–5.62) | 0.391 | 4.33 (1.30–14.43) | |
| No | 1.00 | 1.00 | ||
| Yes | 1.00 (0.58–1.70) | 0.987 | 1.54 (0.88–2.69) | 0.133 |
| No | 1.00 | 1.00 | ||
| Yes | 2.25 (0.45–11.33) | 0.326 | 2.91 (0.85–9.92) | 0.088 |
PV: Pharmacovigilance; ADRs: adverse drug reactions; COR: Crude Odds Ratio; 95% CI = 95% Confidence interval for crude odds ratio. p-values were generated using Pearson Chi-square test.
Significant factors independently associated with ADR reporting among private and government physicians in Kuwait using stepwise multiple logistic regression analyses.
| Factors | Private | p-value | Government | p-value |
|---|---|---|---|---|
| AOR (95% CI) | AOR (95% CI) | |||
| Kuwaiti | 1.00 | |||
| Non-Kuwaiti | 1.99 (1.17–3.40) | |||
| 20–29 | 1.00 | |||
| 30–39 | 1.68 (0.80–3.51) | 0.171 | ||
| 40–49 | 2.26 (1.01–5.04) | |||
| ≥50 | 4.77 (2.06–11.05) | |||
| No | 1.00 | 1.00 | ||
| Yes | 1.86 (1.04–3.33) | 2.55 (1.40–4.64) | ||
| No | 1.00 | 1.00 | ||
| Yes | 2.88 (1.19–7.00) | 4.72 (1.60–13.92) | ||
ADRs: adverse drug reactions; COR: Crude Odds Ratio; 95% CI = 95% Confidence interval for crude odds ratio. p-values were generated using Pearson Chi-square test.
Fig. 4Barriers towards reporting ADRs as reported by private and government physicians (n = 852)*. ADRs: adverse drug reactions. *Multiple responses were possible.